Volpara Health Technologies Ltd. (AU:VHT) has released an update.
Volpara Health Technologies Ltd., a leading software provider for cancer care, has received the final orders from the New Zealand High Court for its scheme of arrangement with Lunit Inc. This strategic move is set to enhance Volpara’s offerings in AI-powered image analysis for mammography and support healthcare providers worldwide. With a strong presence in the US and Australia, the company continues to advance in streamlining operations and improving mammogram quality amidst industry challenges.
For further insights into AU:VHT stock, check out TipRanks’ Stock Analysis page.
